20240050397. LOW DOSE THERAPEUTIC TREATMENT simplified abstract (Syqe Medical Ltd.)

From WikiPatents
Revision as of 03:20, 16 February 2024 by Wikipatents (talk | contribs) (Creating a new page)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

LOW DOSE THERAPEUTIC TREATMENT

Organization Name

Syqe Medical Ltd.

Inventor(s)

Perry Davidson of Tel-Aviv (IL)

Seth Kindler of Tel-Aviv (IL)

Shlomo Almog of Reut (IL)

Binyamin Schwartz of Sde Eliezer (IL)

Aaron Schorr of Misgav (IL)

Daniella Atzmony of odiin-Maccabim-Reut (IL)

LOW DOSE THERAPEUTIC TREATMENT - A simplified explanation of the abstract

This abstract first appeared for US patent application 20240050397 titled 'LOW DOSE THERAPEUTIC TREATMENT

Simplified Explanation

The patent application describes a system for delivering a predetermined amount of THC to a subject. The system includes a memory that stores a scheduled regimen for THC delivery, defining the maximum amount of THC (0.75 mg or less) and the time period (2 hours or longer) within which it is delivered. A decision module determines if a delivery should take place based on the scheduled regimen. An inhaler device, controlled by a controller, is used to deliver the THC based on the decision made by the decision module.

  • The system delivers a specific amount of THC to a subject according to a scheduled regimen.
  • The maximum amount of THC delivered is 0.75 mg or less.
  • The delivery of THC occurs within a time period of 2 hours or longer.
  • A decision module determines if a delivery should take place based on the scheduled regimen.
  • An inhaler device is used to deliver the THC to the subject.
  • The inhaler device is controlled by a controller that carries out the delivery based on the decision made by the decision module.

Potential Applications:

  • Medical treatment: The system can be used in medical settings to deliver controlled amounts of THC to patients for therapeutic purposes, such as pain management or symptom relief.
  • Research and experimentation: The system can be utilized in scientific studies to investigate the effects of THC on the human body and its potential applications in various fields.

Problems Solved:

  • Controlled delivery: The system ensures that a predetermined amount of THC is delivered to the subject within a specific time period, allowing for precise dosing and avoiding potential overdose or underdose.
  • Compliance with regulations: The system helps in adhering to regulations and guidelines regarding the delivery of THC, ensuring that the maximum amount and time period are not exceeded.

Benefits:

  • Precise dosing: The system allows for accurate delivery of THC, ensuring that the subject receives the intended amount within the specified time period.
  • Safety and control: By limiting the maximum amount and time period of THC delivery, the system helps prevent potential adverse effects and provides a controlled environment for THC administration.
  • Convenience: The use of an inhaler device makes the delivery process more convenient and user-friendly compared to other methods of THC administration.


Original Abstract Submitted

some embodiments of the invention relate to a system for delivering to a subject at least one pre-determined amount of thc, the system comprising: a memory which stores a scheduled regimen for delivery of thc to the subject, the scheduled regimen defining: a maximal amount of thc to be delivered, the amount being 0.75 mg thc or less, and a time period within which that amount is delivered, the time period being 2 hours or longer; a decision module which decides, according to the scheduled regimen, if a delivery should take place; and an inhaler device for delivering thc to the subject, the inhaler device comprising a controller which carries out delivery of thc based on the decision made by the decision module.